Essential Medicines in Universal Health Coverage: A Scoping Review of Public Health Law Interventions and How They Are Measured in Five Middle-Income Countries
Анотація
Very few studies exist of legal interventions (national laws) for essential medicines as part of universal health coverage in middle-income countries, or how the effect of these laws is measured. This study aims to critically assess whether laws related to universal health coverage use five objectives of public health law to promote medicines affordability and financing, and to understand how access to medicines achieved through these laws is measured. This comparative case study of five middle-income countries (Ecuador, Ghana, Philippines, South Africa, Ukraine) uses a public health law framework to guide the content analysis of national laws and the scoping review of empirical evidence for measuring access to medicines. Sixty laws were included. All countries write into national law: (a) health equity objectives, (b) remedies for users/patients and sanctions for some stakeholders, (c) economic policies and regulatory objectives for financing (except South Africa), pricing, and benefits selection (except South Africa), (d) information dissemination objectives (ex. for medicines prices (except Ghana)), and (e) public health infrastructure. The 17 studies included in the scoping review evaluate laws with economic policy and regulatory objectives (n = 14 articles), health equity (n = 10), information dissemination (n = 3), infrastructure (n = 2), and sanctions (n = 1) (not mutually exclusive). Cross-sectional descriptive designs (n = 8 articles) and time series analyses (n = 5) were the most frequent designs. Change in patients’ spending on medicines was the most frequent outcome measure (n = 5). Although legal interventions for pharmaceuticals in middle-income countries commonly use all objectives of public health law, the intended and unintended effects of economic policies and regulation are most frequently investigated.
Класифікація
Ідентифікатори
Рецензії (0)
Написати рецензіюРецензій ще немає. Будьте першим!
Схожі роботи
A roadmap towards implementing health technology assessment in Oman
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
Scientific generalization of approaches to the development of the Health Technology Assessment system in international practice
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
Methodological guidelines for Health Technology Assessment in Oman
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
The relevance of training specialists in the Health Technology Assessment in the world and Ukraine
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy
Quality indicators in health care systems: National Resources Focus on Results, Processes and Productivity
Схоже за: Health Systems, Economic Evaluations, Quality of Life · Healthcare Systems and Reforms